Home
>
National Drug Code (NDC)
>
Etoposide
Etoposide - 55390-292-01 - (Etoposide)
Drug Information of Etoposide
| Product NDC: | 55390-292 |
| Proprietary Name: | Etoposide |
| Non Proprietary Name: | Etoposide |
| Active Ingredient(s): | 20 mg/mL & nbsp; Etoposide |
| Administration Route(s): | INTRAVENOUS |
| Dosage Form(s): | INJECTION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Etoposide
| Product NDC: | 55390-292 |
| Labeler Name: | Bedford Laboratories |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA074290 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 19970201 |
Package Information of Etoposide
| Package NDC: | 55390-292-01 |
| Package Description: | 1 VIAL in 1 BOX, UNIT-DOSE (55390-292-01) > 25 mL in 1 VIAL |
NDC Information of Etoposide
| NDC Code | 55390-292-01 |
| Proprietary Name | Etoposide |
| Package Description | 1 VIAL in 1 BOX, UNIT-DOSE (55390-292-01) > 25 mL in 1 VIAL |
| Product NDC | 55390-292 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Etoposide |
| Dosage Form Name | INJECTION |
| Route Name | INTRAVENOUS |
| Start Marketing Date | 19970201 |
| Marketing Category Name | ANDA |
| Labeler Name | Bedford Laboratories |
| Substance Name | ETOPOSIDE |
| Strength Number | 20 |
| Strength Unit | mg/mL |
| Pharmaceutical Classes | Topoisomerase Inhibitor [EPC],Topoisomerase Inhibitors [MoA] |
